Mark J Levin - Net Worth and Insider Trading

Mark J Levin Net Worth

The estimated net worth of Mark J Levin is at least $366 Million dollars as of 2024-11-13. Mark J Levin is the 10% Owner of Blueprint Medicines Corp and owns about 3,564,997 shares of Blueprint Medicines Corp (BPMC) stock worth over $344 Million. Mark J Levin is also the Director, 10% Owner of Fulcrum Therapeutics Inc and owns about 5,962,202 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $22 Million. Details can be seen in Mark J Levin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark J Levin has not made any transactions after 2019-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark J Levin

To

Mark J Levin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark J Levin owns 22 companies in total, including Revolution Medicines Inc (RVMD) , Nurix Therapeutics Inc (NRIX) , and Relay Therapeutics Inc (RLAY) among others .

Click here to see the complete history of Mark J Levin’s form 4 insider trades.

Insider Ownership Summary of Mark J Levin

Ticker Comapny Transaction Date Type of Owner
RVMD Revolution Medicines Inc 2020-02-12 10 percent owner
NRIX Nurix Therapeutics Inc 2020-07-23 10 percent owner
RLAY Relay Therapeutics Inc 2020-07-15 10 percent owner
LIMIT LIMIT 2020-06-11 director & 10 percent owner
LIMIT LIMIT 2020-06-02 10 percent owner
LIMIT LIMIT 2016-12-19 director & 10 percent owner
LIMIT LIMIT 2017-10-04 10 percent owner
LIMIT LIMIT 2018-08-22 10 percent owner
LIMIT LIMIT 2018-06-29 10 percent owner
LIMIT LIMIT 2018-03-07 10 percent owner
LIMIT LIMIT 2017-11-01 10 percent owner
LIMIT LIMIT 2016-11-07 10 percent owner
LIMIT LIMIT 2016-11-03 10 percent owner
LIMIT LIMIT 2017-03-16 10 percent owner
LIMIT LIMIT 2017-01-26 10 percent owner
LIMIT LIMIT 2016-05-16 10 percent owner
LIMIT LIMIT 2016-02-02 10 percent owner
LIMIT LIMIT 2015-03-24 10 percent owner
LIMIT LIMIT 2015-05-14 10 percent owner
LIMIT LIMIT 2014-02-11 director & 10 percent owner
LIMIT LIMIT 2021-02-11 10 percent owner
LIMIT LIMIT 2014-02-11 director & 10 percent owner

Mark J Levin Latest Holdings Summary

Mark J Levin currently owns a total of 2 stocks. Among these stocks, Mark J Levin owns 3,564,997 shares of Blueprint Medicines Corp (BPMC) as of March 16, 2017, with a value of $344 Million and a weighting of 94.06%. Mark J Levin also owns 5,962,202 shares of Fulcrum Therapeutics Inc (FULC) as of July 22, 2019, with a value of $22 Million and a weighting of 5.94%.

Latest Holdings of Mark J Levin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BPMC Blueprint Medicines Corp 2017-03-16 3,564,997 96.63 344,485,660
FULC Fulcrum Therapeutics Inc 2019-07-22 5,962,202 3.65 21,762,037

Holding Weightings of Mark J Levin


Mark J Levin Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark J Levin has made a total of 0 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years. The most-recent trade in Blueprint Medicines Corp is the sale of 30,000 shares on March 16, 2017, which brought Mark J Levin around $1 Million.

According to the SEC Form 4 filings, Mark J Levin has made a total of 0 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 81,250 shares on July 22, 2019, which cost Mark J Levin around $1 Million.

Insider Trading History of Mark J Levin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark J Levin Trading Performance

GuruFocus tracks the stock performance after each of Mark J Levin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark J Levin is -59.61%. GuruFocus also compares Mark J Levin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark J Levin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark J Levin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark J Levin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.3 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.22 LIMIT LIMIT LIMIT LIMIT LIMIT

Mark J Levin Ownership Network

Ownership Network List of Mark J Levin

No Data

Ownership Network Relation of Mark J Levin

Insider Network Chart

Mark J Levin Owned Company Details

What does Revolution Medicines Inc do?

Who are the key executives at Revolution Medicines Inc?

Mark J Levin is the 10 percent owner of Revolution Medicines Inc. Other key executives at Revolution Medicines Inc include General Counsel Jeff Cislini , director & See Remarks Mark A Goldsmith , and See Remarks Stephen Michael Kelsey .

Revolution Medicines Inc (RVMD) Insider Trades Summary

Over the past 18 months, Mark J Levin made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 34,044 shares made by Jeff Cislini , a net sale of 186,391 shares made by Stephen Michael Kelsey , and a net sale of 265,672 shares made by Mark A Goldsmith .

In summary, during the past 3 months, insiders sold 249,942 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 249,942 shares. During the past 18 months, 718,995 shares of Revolution Medicines Inc (RVMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 718,995 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Revolution Medicines Inc Insider Transactions

No Available Data

Mark J Levin Mailing Address

Above is the net worth, insider trading, and ownership report for Mark J Levin. You might contact Mark J Levin via mailing address: 29 Newbury Street, 3rd Floor, Boston Ma 02116.